These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

44 related articles for article (PubMed ID: 6476776)

  • 1. Reversal of aluminium inhibition of enzymatic O-methylation by desferrioxamine.
    Casson IF; Harvey JN; Lee MR
    Ann Clin Biochem; 1984 May; 21 ( Pt 3)():223. PubMed ID: 6476776
    [No Abstract]   [Full Text] [Related]  

  • 2. Radioenzymatic assay of catecholamines: reversal of aluminium inhibition of enzymatic O-methylation by desferrioxamine.
    Mason L; Weinkove C
    Ann Clin Biochem; 1983 Mar; 20 Pt 2():105-11. PubMed ID: 6847115
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Desferrioxamine-induced changes of aluminium kinetics during haemodialysis.
    Graf H; Stummvoll HK; Meisinger V
    Proc Eur Dial Transplant Assoc; 1981; 18():674-80. PubMed ID: 7329995
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Partial reversal of aluminium-induced neurofibrillary degeneration by desferrioxamine in adult male rabbits.
    Savory J; Herman MM; Erasmus RT; Boyd JC; Wills MR
    Neuropathol Appl Neurobiol; 1994 Feb; 20(1):31-7. PubMed ID: 8208339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Confirmation of 2-O-methyl ascorbic acid as the product from the enzymatic methylation of L-ascorbic acid by catechol-O-methyltransferase.
    Bowers-Komro DM; McCormick DB; King GA; Sweeny JG; Iacobucci GA
    Int J Vitam Nutr Res; 1982; 52(2):186-93. PubMed ID: 7129800
    [No Abstract]   [Full Text] [Related]  

  • 6. [The effect of desferrioxamine in aluminum-processing workers].
    Hosovski E; Vidaković A
    Srp Arh Celok Lek; 1990; 118(9-10):341-5. PubMed ID: 2102549
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Desferrioxamine, aluminium, and dialysis.
    Simon P; Ang KS; Cam G; Allain P; Mauras Y
    Lancet; 1983 Dec 24-31; 2(8365-66):1489-90. PubMed ID: 6140572
    [No Abstract]   [Full Text] [Related]  

  • 8. Strong inhibitory effects of common tea catechins and bioflavonoids on the O-methylation of catechol estrogens catalyzed by human liver cytosolic catechol-O-methyltransferase.
    Nagai M; Conney AH; Zhu BT
    Drug Metab Dispos; 2004 May; 32(5):497-504. PubMed ID: 15100171
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Catechol-O-methyltransferase: substrate-specificity and stereoselectivity for beta-adrenoceptor agents.
    Raxworthy MJ; Youde IR; Gulliver PA
    Xenobiotica; 1986 Jan; 16(1):47-52. PubMed ID: 2868577
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of desferrioxamine on aluminum kinetics during hemodialysis.
    Stummvoll HK; Graf H; Meisinger V
    Miner Electrolyte Metab; 1984; 10(4):263-6. PubMed ID: 6749073
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phenol ionization in dopa determines the site of methylation by catechol-O-methyltransferase.
    Firnau G; Sood S; Pantel R; Garnett S
    Mol Pharmacol; 1981 Jan; 19(1):130-3. PubMed ID: 6782443
    [No Abstract]   [Full Text] [Related]  

  • 12. O-Methylation of tea polyphenols catalyzed by human placental cytosolic catechol-O-methyltransferase.
    Zhu BT; Patel UK; Cai MX; Conney AH
    Drug Metab Dispos; 2000 Sep; 28(9):1024-30. PubMed ID: 10950844
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methylation pharmacogenetics: catechol O-methyltransferase, thiopurine methyltransferase, and histamine N-methyltransferase.
    Weinshilboum RM; Otterness DM; Szumlanski CL
    Annu Rev Pharmacol Toxicol; 1999; 39():19-52. PubMed ID: 10331075
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enantioselectivity in the methylation of the catecholic phase I metabolites of methylenedioxy designer drugs and their capability to inhibit catechol-O-methyltransferase-catalyzed dopamine 3-methylation.
    Meyer MR; Maurer HH
    Chem Res Toxicol; 2009 Jun; 22(6):1205-11. PubMed ID: 19462939
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Catechol metabolites of polychlorinated biphenyls inhibit the catechol-O-methyltransferase-mediated metabolism of catechol estrogens.
    Garner CE; Burka LT; Etheridge AE; Matthews HB
    Toxicol Appl Pharmacol; 2000 Jan; 162(2):115-23. PubMed ID: 10637135
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Involvement of altered cytoskeletal protein phosphorylation in aluminum-induced CNS dysfunction.
    Julka D; Gill KD
    J Biochem Toxicol; 1996; 11(5):227-33. PubMed ID: 9110244
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biochemical and molecular modeling studies of the O-methylation of various endogenous and exogenous catechol substrates catalyzed by recombinant human soluble and membrane-bound catechol-O-methyltransferases.
    Bai HW; Shim JY; Yu J; Zhu BT
    Chem Res Toxicol; 2007 Oct; 20(10):1409-25. PubMed ID: 17880176
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of intravenous and intraperitoneal desferrioxamine in aluminium osteomalacia.
    O'Brien AA; McParland C; Keogh JA
    Nephrol Dial Transplant; 1987; 2(2):117-9. PubMed ID: 3112649
    [TBL] [Abstract][Full Text] [Related]  

  • 19. O-methylation of (+)-(R)- and (-)-(S)-6,7-dihydroxy-1-methyl-1,2,3,4-tetrahydroisoquinoline (salsolinol) in the presence of pig brain catechol-O-methyltransferase.
    Hötzl BK; Thomas H
    Chirality; 1997; 9(4):367-72. PubMed ID: 9275315
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of aluminium intoxication: a new scheme for desferrioxamine administration.
    Douthat WG; Acuña Aguerre G; Fernández Martín JL; Mouzo R; Cannata Andía JB
    Nephrol Dial Transplant; 1994; 9(10):1431-4. PubMed ID: 7816256
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.